{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:51:38Z","timestamp":1787964698504,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymgme.2026.109762","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:45:29Z","timestamp":1770565529000},"page":"109762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lessons from late-onset Pompe disease identified by Newborn screening: A systematic review"],"prefix":"10.1016","volume":"147","author":[{"given":"Myriam","family":"Boueri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Doxey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Nading","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2026.109762_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.109762_bb0010","first-page":"45","article-title":"Postmortem findings and clinical correlates in individuals with infantile-onset Pompe disease","volume":"23","author":"Pena","year":"2015","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ymgme.2026.109762_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.109762_bb0035","article-title":"A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment","volume":"164a(1):54-61","author":"Yang","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.ymgme.2026.109762_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41436-020-01080-y","article-title":"Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction","volume":"23","author":"Li","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.109762_bb0045","article-title":"Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease","volume":"4","author":"Desai","year":"2026","journal-title":"Genet. Med. Open"},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","volume":"269","author":"Sarah","year":"2022","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2022.01.001","article-title":"Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease","volume":"32","author":"Winkler","year":"2022","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jimd.12560","article-title":"Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism","volume":"46","author":"Canibano-Fraile","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2026.109762_bb0065","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1093\/brain\/awae249","article-title":"Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression","volume":"147","author":"Monceau","year":"2024","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ymgme.2026.109762_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091339","article-title":"Pompe disease: new developments in an old lysosomal storage disorder","volume":"10","author":"Meena","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.ymgme.2026.109762_bb0075","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161a","author":"Kishnani","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2022.01.003","article-title":"Early clinical phenotype of late onset Pompe disease: lessons learned from newborn screening","volume":"135","author":"Huggins","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymgme.2018.08.009","article-title":"Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13\u00a0T\u00a0>\u00a0G variant","volume":"126","author":"Herbert","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0090","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.109762_bb0095","series-title":"Newborn Screening Status for All Disorders","author":"NewSteps","year":"2025"},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"13","key":"10.1016\/j.ymgme.2026.109762_bb0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.21037\/atm.2019.04.13","article-title":"Molecular genetics of Pompe disease: a comprehensive overview","volume":"7","author":"Peruzzo","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.109762_bb0110","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1542\/peds.2016-0280E","article-title":"Management of Confirmed Newborn-Screened Patients with Pompe Disease across the disease Spectrum","volume":"140","author":"Kronn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.109762_bb0115","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.ymgme.2026.109762_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2021.12.072","article-title":"Outcome of later-onset Pompe disease identified through newborn screening","volume":"244","author":"Lee","year":"2022","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2026.109762_bb0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2026.109762_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: The initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for Pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109762_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2026.109762_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpeds.2018.02.007","article-title":"Severe cardiac involvement is rare in patients with late-onset Pompe disease and the common c.-32-13T>G variant: implications for Newborn screening","volume":"198","author":"Herbert","year":"2018","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijns11010016","article-title":"Five-year outcomes of patients with Pompe disease identified by the Pennsylvania newborn screen","volume":"11","author":"Ron","year":"2025","journal-title":"Int J neonatal Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2017.09.008","article-title":"Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G \u201clate-onset\u201d GAA variant","volume":"122","author":"Rairikar","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109762_bb0175","article-title":"Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening","volume":"36","author":"Jackson","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bib246","doi-asserted-by":"crossref","first-page":"109357","DOI":"10.1016\/j.ymgme.2025.109357","article-title":"Early enzyme replacement therapy in late onset Pompe disease diagnosed by newborn screening","volume":"147","author":"Case","year":"2026","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.109762_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2021.09.001","article-title":"Health care practitioners\u2019 experience-based opinions on providing care after a positive newborn screen for Pompe disease","volume":"134","author":"Davids","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.109762_bb0185","article-title":"Disparities in late and lost: Pediatricians\u2019 role in following Pompe disease identified by newborn screening","volume":"140","author":"Pillai","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.109762_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2016.07.009","article-title":"Patients\u2019 perspectives on newborn screening for later-onset lysosomal storage diseases","volume":"119","author":"Lisi","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2026.109762_bb0195","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/jgc4.1421","article-title":"Opinions of adults affected with later-onset lysosomal storage diseases regarding newborn screening: a qualitative study","volume":"30","author":"Lisi","year":"2021","journal-title":"J. Genet. Couns."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijns8030043","article-title":"A qualitative study: mothers\u2019 experiences of their child\u2019s late-onset Pompe disease diagnosis following newborn screening","volume":"8","author":"Crossen","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"issue":"6","key":"10.1016\/j.ymgme.2026.109762_bb0205","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/jgc4.1615","article-title":"Newborn screening for Pompe disease: parental experiences and follow-up care for a late-onset diagnosis","volume":"31","author":"Prakash","year":"2022","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2026.109762_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2025.08.003","article-title":"Navigating the emotional and practical challenges of Newborn screening for late-onset Pompe disease: insights from parental perspectives","volume":"172","author":"Boueri","year":"2025","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ymgme.2026.109762_bb0220","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (\u221213T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation","volume":"3","author":"Huie","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.109762_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-7-73","article-title":"Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study","volume":"7","author":"de Vries","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109762_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T\u2192G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ymgme.2026.109762_bb0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s10038-019-0603-7","article-title":"Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients","volume":"64","author":"Momosaki","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109762_bb0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","article-title":"Rapid progressive course of later-onset Pompe disease in Chinese patients","volume":"104","author":"Yang","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109762_bb0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160c","author":"Young","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:18:31Z","timestamp":1776190711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1096719226000454"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109762","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from late-onset Pompe disease identified by Newborn screening: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109762"}}